Exploring the Mental Health of Parents Having Children With Cancer

May 27, 2019 updated by: The University of Hong Kong

An Exploratory Study of Resilience in Parents of Children With Cancer

Caring for children with cancer is described as life-changing experience and overwhelming stress for parents. Poor quality of life and mental health problems such as depression and anxiety were found in this population. The psychological status of them is still waited to be improved. As a dominant term in positive psychology, resilience is commonly regarded as the ability to move forward or keep normal under adversity. It was proved to be associated with psychological outcomes in adolescents and chronic illness patients, enhanced resilience usually along with improved mental health, while little evidence was available in the parents of children with cancer.

A cross-sectional study will be conducted to explore the level of resilience and psychological outcomes such as quality of life, depression, anxiety and well-being in parents of children with cancer using questionnaires. Such results will be compared with normal population to help evaluate the psychological status of those parents. The relationship between resilience and these psychological outcomes will also be examined. Lower resilience and higher resilience of the parents will be determined by the lowest and highest quartile of The Connor-Davidson Resilience Scale (CD-RISC) scores. Subsequently, a qualitative study will be conducted to explore the experience of those parents with lower resilience and higher resilience.

It is anticipated that risk parents of children with cancer could be identified from the inferior outcomes of resilience and psychological outcomes. Both the results of cross-sectional study and qualitative study will guide the development of interventions designed to enhance resilience and promote positive psychological outcomes among targeted parents of children with cancer under risk.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

181

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Hong Kong
      • Hong Kong, Hong Kong
        • The university of Hong Kong

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Parents having children with cancer who are treated at a tertiary hospital in Mainland China between September 2018 and December 2018 will be recruited.

Description

Inclusion Criteria:

  • have a child (0-19 years old) with cancer diagnosis. Chinese resident and can read Chinese and speak Mandarin.

Exclusion Criteria:

  • have physical impairment or cognitive and learning problems identified from family history of medical records.

attending other researches.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
parents having children with cancer
No intervention.
Other: Exposure_having children with cancer
No intervention. The exposure is having children with cancer.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Resilience measurement by using the Connor-Davidson resilience scale.
Time Frame: A cross-sectional study will be conducted during September 2018 and January 2019. The measurement will be taken once for each participant.
Resilience of parents having children with cancer will be measured. The total score ranges from 0-100 and higher score reflecting higher level of resilience.
A cross-sectional study will be conducted during September 2018 and January 2019. The measurement will be taken once for each participant.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life measurement by using the Short Form 6D (SF-6D).
Time Frame: A cross-sectional study will be conducted during September 2018 and January 2019. The measurement will be taken once for each participant.
Quality of life of parents having children with cancer will be measured. The total score ranges from 0.32 for the worst health state to 1 for full health.
A cross-sectional study will be conducted during September 2018 and January 2019. The measurement will be taken once for each participant.
Depression measurement by using self-rating depression scale.
Time Frame: A cross-sectional study will be conducted during September 2018 and January 2019. The measurement will be taken once for each participant.
Depression of parents having children with cancer will be measured. The total score ranges from 20 to 80. Higher total score indicates more serious depression status.
A cross-sectional study will be conducted during September 2018 and January 2019. The measurement will be taken once for each participant.
Anxiety measurement by using self-rating anxiety scale.
Time Frame: A cross-sectional study will be conducted during September 2018 and January 2019. The measurement will be taken once for each participant.
Anxiety of parents having children with cancer will be measured. The total score ranges from 25 to 100 and higher score reflects worse anxiety status.
A cross-sectional study will be conducted during September 2018 and January 2019. The measurement will be taken once for each participant.
Stress measurement by using perceived stress scale.
Time Frame: A cross-sectional study will be conducted during September 2018 and January 2019. The measurement will be taken once for each participant.
Stress of parents having children with cancer will be measured. The total score ranges from 0 to 40. Higher total score suggests more perceived stress.
A cross-sectional study will be conducted during September 2018 and January 2019. The measurement will be taken once for each participant.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

The University of Hong Kong

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 27, 2018

Primary Completion (ACTUAL)

November 27, 2018

Study Completion (ACTUAL)

November 27, 2018

Study Registration Dates

First Submitted

August 7, 2018

First Submitted That Met QC Criteria

August 10, 2018

First Posted (ACTUAL)

August 15, 2018

Study Record Updates

Last Update Posted (ACTUAL)

May 30, 2019

Last Update Submitted That Met QC Criteria

May 27, 2019

Last Verified

May 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • UW 18-371

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Resilience of Parents Having Children With Cancer

Clinical Trials on Exposure_having children with cancer

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe